TITLE
Gefitinib effect on various non-small cell lung cancer cell lines (HG-U133B)

SUMMARY
Analysis of baseline non-small cell lung cancer (NSCLC) cell lines with a broad range of sensitivity to the anticancer drug gefitinib. Gefitinib is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). Results used to define a gene expression signature of gefitinib sensitivity.

ORGANISM
Homo sapiens

